# Medtronic

> Medtronic is a global medical-technology company that develops, manufactures, and sells implantable devices, surgical systems, patient-monitoring tools, and connected therapies. Its portfolio reaches from pacemakers, ablation catheters, and heart valves to spine navigation, neurostimulation, surgical robotics, and insulin-delivery systems, serving hospitals, clinicians, health systems, and patients in more than 150 countries.

- **Founded:** 1949
- **Headquarters:** Galway, Ireland
- **Founders:** Earl E. Bakken (Co-founder and longtime CEO/chairman), Palmer J. Hermundslie (Co-founder)
- **Team size:** More than 95,000 full-time employees as of fiscal 2026; 43% were based in the United States or Puerto Rico.
- **Products:** Cardiovascular portfolio, Hugo robotic-assisted surgery system, Medical Surgical portfolio, Neuroscience portfolio, MiniMed 780G
- **Notable:** Developed the first battery-powered external pacemaker in 1957 after a hospital power failure exposed the danger of plug-in systems., Grew from a Minneapolis repair shop into a company operating across more than 150 countries and treating more than 70 health conditions., Completed the approximately $50 billion acquisition of Covidien in 2015, greatly expanding its surgical and monitoring portfolio.

## Products & services

- **Cardiovascular portfolio** — Pacemakers, implantable defibrillators, cardiac resynchronization systems, ablation and mapping technologies, heart valves, stents, balloons, renal denervation, and remote cardiac monitoring.
- **Hugo robotic-assisted surgery system** — A modular soft-tissue surgical robot paired with the Touch Surgery digital ecosystem; cleared in the United States for urologic procedures in 2025.
- **Medical Surgical portfolio** — Surgical stapling and energy instruments, endoscopy, airway management, ventilation, pulse oximetry, patient monitoring, and acute-care technologies.
- **Neuroscience portfolio** — Spine and cranial navigation, surgical imaging, deep-brain and spinal-cord stimulation, pain therapies, pelvic health, ENT, and neurovascular devices.
- **MiniMed 780G** — An automated insulin-delivery system combining an insulin pump, continuous glucose monitoring, and adaptive dosing software.
- **Micra transcatheter pacing systems** — Miniaturized leadless pacemakers implanted directly in the heart through a catheter-based procedure.
- **Affera cardiac mapping and ablation system** — An integrated platform for mapping arrhythmias and delivering pulsed-field or radiofrequency ablation through the Sphere-9 catheter.
- **Integrated Health Solutions** — Hospital consulting, managed services, pathway redesign, training, and operational support intended to improve clinical and financial outcomes.

## Achievements

- Developed the first battery-powered external pacemaker in 1957 after a hospital power failure exposed the danger of plug-in systems.
- Grew from a Minneapolis repair shop into a company operating across more than 150 countries and treating more than 70 health conditions.
- Completed the approximately $50 billion acquisition of Covidien in 2015, greatly expanding its surgical and monitoring portfolio.
- Pioneered major categories including leadless pacing with Micra and commercial deep-brain stimulation for movement disorders.
- Received U.S. FDA clearance for the Hugo robotic-assisted surgery system in urology in December 2025.
- Reported $36.364 billion in fiscal 2026 revenue, its strongest annual reported revenue growth in a decade.
- Was named to the 2026 TIME100 Companies list in the Health category for Hugo and the Touch Surgery ecosystem.
- Raised its dividend for the 49th consecutive year in June 2026.

## Latest updates

- **2026-07** — Completed the $650 million acquisition of SPR Therapeutics, adding temporary peripheral nerve stimulation for pain management.
- **2026-06** — Reported fiscal 2026 revenue of $36.364 billion, up 8.4% as reported and 5.8% organically.
- **2026-06** — Completed the $550 million acquisition of Scientia Vascular to add neurovascular access technologies.
- **2026-06** — Submitted U.S. filings to expand Hugo into general and gynecologic surgery and received clearance for ProGrip Advanced mesh.
- **2026-04** — Completed the acquisition of CathWorks, adding the wire-free FFRangio coronary physiology system.
- **2026-02** — The first U.S. commercial Hugo procedure was performed at Cleveland Clinic.
- **2025-12** — Filed an IPO registration statement for the planned separation of the diabetes business under the MiniMed name.
- **2025-12** — Received FDA clearance for Hugo in urologic surgical procedures.

## Links

- Website: https://www.medtronic.com/
- LinkedIn: https://www.linkedin.com/company/medtronic
- Twitter/X: https://x.com/Medtronic
- YouTube: https://www.youtube.com/@MedtronicCorporate
- Instagram: https://www.instagram.com/medtronic/
- Facebook: https://www.facebook.com/Medtronic/

---

Profile page: https://yespress.io/medtronic
Published by YesPress — https://yespress.io
Last updated: 2026-08-11